Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gillespie

Showing results (591-600 of 623) with videos related to

Pageof 63
Sort By:
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 12, 2019
Genome-Wide Meta-Analyses of FTND and TTFC PhenotypesJingchun Chen, Anu Loukola, Nathan A Gillespie, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Nature Medicine|December 7, 2023
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individualsHang Zhou, Rachel L Kember, Joseph D Deak, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Multi-ancestry study of the genetics of problematic alcohol use in >1 million individualsHang Zhou, Rachel L Kember, Joseph D Deak, et al.
NPJ Vaccines|September 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccineJoseph P Casazza, Amelia R Hofstetter, Pamela J M Costner, et al.
Nature Neuroscience|June 7, 2019
Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liabilityJoëlle A Pasman, Karin J H Verweij, Zachary Gerring, et al.
Nature Neuroscience|August 29, 2018
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophreniaJoëlle A Pasman, Karin J H Verweij, Zachary Gerring, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Multi-ancestral genome-wide association study of clinically defined nicotine dependence reveals strong genetic correlations with other substance use disorders and health-related traitsEmma C Johnson, Dongbing Lai, Alex P Miller, et al.
Pageof 63

Showing results (591-600 of 623) with videos related to

Sort By:
Pageof 63
Journal of Virology|November 10, 2025
Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivityParker J Jamieson, Xiaoying Shen, Alexandra A Abu-Shmais, et al.
Nature Medicine|February 4, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trialKatherine V Houser, Grace L Chen, Cristina Carter, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 12, 2019
Genome-Wide Meta-Analyses of FTND and TTFC PhenotypesJingchun Chen, Anu Loukola, Nathan A Gillespie, et al.
Science Translational Medicine|April 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adultsAlicia T Widge, Amelia R Hofstetter, Katherine V Houser, et al.
Nature Medicine|December 7, 2023
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individualsHang Zhou, Rachel L Kember, Joseph D Deak, et al.
Medrxiv : the Preprint Server for Health Sciences|February 7, 2023
Multi-ancestry study of the genetics of problematic alcohol use in >1 million individualsHang Zhou, Rachel L Kember, Joseph D Deak, et al.
NPJ Vaccines|September 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccineJoseph P Casazza, Amelia R Hofstetter, Pamela J M Costner, et al.
Nature Neuroscience|June 7, 2019
Author Correction: GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liabilityJoëlle A Pasman, Karin J H Verweij, Zachary Gerring, et al.
Nature Neuroscience|August 29, 2018
GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophreniaJoëlle A Pasman, Karin J H Verweij, Zachary Gerring, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Multi-ancestral genome-wide association study of clinically defined nicotine dependence reveals strong genetic correlations with other substance use disorders and health-related traitsEmma C Johnson, Dongbing Lai, Alex P Miller, et al.
Pageof 63